The company’s bottom line took a hit as premium revenue declined by 6%, a trend management attributed to shrinking enrollment numbers. Despite the earnings slump, the firm’s adjusted earnings per share of $1.51 managed to edge past the $1.39 consensus estimate from FactSet analysts. Chief Executive Joseph Zubretsky noted that the misalignment between Medicaid reimbursement rates and actual medical expenses has started to stabilize. He anticipates 2026 will serve as a low point for Medicaid margins, clearing a path for a return to profitable growth by 2027.
In section Market Quotes
Molina Healthcare Profit Slides Amid Membership Contraction
A sharp drop in membership and rising medical costs forced Molina Healthcare to report a second-quarter net income of $60 million, down significantly from the $255 million recorded a year ago. The insurer, which centers its business on Medicare and Medicaid, saw its quarterly revenue slip to $10.87 billion.
Looking ahead, Molina raised its fiscal 2026 outlook, projecting adjusted earnings of at least $5.25 per share. This forecast accounts for specific headwinds, including a $1.50 per share loss tied to a new Florida Medicaid contract and a $1.00 per share drag from its traditional Medicare Advantage Prescription Drug (MAPD) product. The company plans to exit the MAPD market entirely by 2027 to focus on more stable segments of its portfolio.
Comments (0)
No comments yet. Be the first!